Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd

<< Previous

Bullboard Posts

Next >>

Post by laroplexon Mar 17, 2020 12:07pm

139 Views

Post# 30817337

Phase 1 Clinical trial!!

Hi MaterialWorld.....You bet this will get EXTREMELY exciting....I know that you are a die hard long term holder as myself....We will get rewarded HUGE.....This n/r today tells us that they will recruiting the worst of the patients....hopefully this trial will start this week.....we know it takes seven days for results....now....if these results can come near or even duplicate what the Chinese did......This stock will go CRAZY and EXPLODE.....hold tight......GLTA

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project